These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 19648932)

  • 1. Allosteric communication between protomers of dopamine class A GPCR dimers modulates activation.
    Han Y; Moreira IS; Urizar E; Weinstein H; Javitch JA
    Nat Chem Biol; 2009 Sep; 5(9):688-95. PubMed ID: 19648932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new mechanism of allostery in a G protein-coupled receptor dimer.
    Lane JR; Donthamsetti P; Shonberg J; Draper-Joyce CJ; Dentry S; Michino M; Shi L; López L; Scammells PJ; Capuano B; Sexton PM; Javitch JA; Christopoulos A
    Nat Chem Biol; 2014 Sep; 10(9):745-52. PubMed ID: 25108820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Asymmetry of GPCR oligomers supports their functional relevance.
    Maurice P; Kamal M; Jockers R
    Trends Pharmacol Sci; 2011 Sep; 32(9):514-20. PubMed ID: 21715028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine D2 Receptors Dimers: How can we Pharmacologically Target Them?
    Carli M; Kolachalam S; Aringhieri S; Rossi M; Giovannini L; Maggio R; Scarselli M
    Curr Neuropharmacol; 2018 Jan; 16(2):222-230. PubMed ID: 28521704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A G protein-coupled receptor dimer imaging assay reveals selectively modified pharmacology of neuropeptide Y Y1/Y5 receptor heterodimers.
    Kilpatrick LE; Humphrys LJ; Holliday ND
    Mol Pharmacol; 2015 Apr; 87(4):718-32. PubMed ID: 25637604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diversity and bias through dopamine D2R heteroreceptor complexes.
    Borroto-Escuela DO; Fuxe K
    Curr Opin Pharmacol; 2017 Feb; 32():16-22. PubMed ID: 27838588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allosteric interactions within the AT₁ angiotensin receptor homodimer: role of the conserved DRY motif.
    Szalai B; Barkai L; Turu G; Szidonya L; Várnai P; Hunyady L
    Biochem Pharmacol; 2012 Aug; 84(4):477-85. PubMed ID: 22579851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allosteric mechanisms within the adenosine A2A-dopamine D2 receptor heterotetramer.
    Ferré S; Bonaventura J; Tomasi D; Navarro G; Moreno E; Cortés A; Lluís C; Casadó V; Volkow ND
    Neuropharmacology; 2016 May; 104():154-60. PubMed ID: 26051403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine D2 receptor signaling dynamics of dopamine D2-neurotensin 1 receptor heteromers.
    Borroto-Escuela DO; Ravani A; Tarakanov AO; Brito I; Narvaez M; Romero-Fernandez W; Corrales F; Agnati LF; Tanganelli S; Ferraro L; Fuxe K
    Biochem Biophys Res Commun; 2013 May; 435(1):140-6. PubMed ID: 23624386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bidirectional allosteric interactions between cannabinoid receptor 1 (CB
    Bagher AM; Laprairie RB; Toguri JT; Kelly MEM; Denovan-Wright EM
    Eur J Pharmacol; 2017 Oct; 813():66-83. PubMed ID: 28734930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postsynaptic D2 dopamine receptor supersensitivity in the striatum of mice lacking TAAR1.
    Espinoza S; Ghisi V; Emanuele M; Leo D; Sukhanov I; Sotnikova TD; Chieregatti E; Gainetdinov RR
    Neuropharmacology; 2015 Jun; 93():308-13. PubMed ID: 25721394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allosteric modulation of heterodimeric G-protein-coupled receptors.
    Milligan G; Smith NJ
    Trends Pharmacol Sci; 2007 Dec; 28(12):615-20. PubMed ID: 18022255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Residues and residue pairs of evolutionary importance differentially direct signaling bias of D2 dopamine receptors.
    Terrón-Díaz ME; Wright SJ; Agosto MA; Lichtarge O; Wensel TG
    J Biol Chem; 2019 Dec; 294(50):19279-19291. PubMed ID: 31676688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intramolecular allosteric communication in dopamine D2 receptor revealed by evolutionary amino acid covariation.
    Sung YM; Wilkins AD; Rodriguez GJ; Wensel TG; Lichtarge O
    Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3539-44. PubMed ID: 26979958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous method for analyzing dimerization and signaling of G-protein-coupled receptor in yeast by dual-color reporter system.
    Nakamura Y; Takemoto N; Ishii J; Kondo A
    Biotechnol Bioeng; 2014 Mar; 111(3):586-96. PubMed ID: 24122388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oligomerization and cooperativity in GPCRs from the perspective of the angiotensin AT1 and dopamine D2 receptors.
    Durdagi S; Erol I; Salmas RE; Aksoydan B; Kantarcioglu I
    Neurosci Lett; 2019 May; 700():30-37. PubMed ID: 29684528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct Dopamine D₂ Receptor Antagonists Differentially Impact D₂ Receptor Oligomerization.
    Wouters E; Marín AR; Dalton JAR; Giraldo J; Stove C
    Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30987329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stoichiometric analysis of oligomeric states of three class-A GPCRs, chemokine-CXCR4, dopamine-D2, and prostaglandin-EP1 receptors, on living cells.
    Kawano K; Yagi T; Fukada N; Yano Y; Matsuzaki K
    J Pept Sci; 2017 Jul; 23(7-8):650-658. PubMed ID: 28626925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D2 dopamine receptor-mediated inhibition of a hyperpolarization-activated current in rod photoreceptors.
    Akopian A; Witkovsky P
    J Neurophysiol; 1996 Sep; 76(3):1828-35. PubMed ID: 8890295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. G protein activation by the leukotriene B4 receptor dimer. Evidence for an absence of trans-activation.
    Damian M; Mary S; Martin A; Pin JP; Banères JL
    J Biol Chem; 2008 Jul; 283(30):21084-92. PubMed ID: 18490452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.